icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
Boston MA
November 2019
Back grey_arrow_rt.gif
 
 
 
Assessing the Real-World Effectiveness and Clinical Efficacy of 8198 Patients Receiving Elbasvir/Grazoprevir for the Treatment of HCV Infection
 
 
  AASLD 2019 Nov 8-11 Boston
 
Jennifer R. Kramer1,2; Amy Puenpatom3; Barbara A. Haber3; Peggy Hwang3; Xian Yu1,2; Fasiha Kanwal1,2 1Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey VA Medical Center, Houston, TX; 2Department of Medicine, Baylor College of Medicine, Houston, TX; 3Merck & Co., Inc., Kenilworth, NJ

0203201

0203202

0203203

0203204

0203205

0203206

0203207